Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19
[...]we propose that measurement of ACE2 level may help identify individuals at risk of severe infection where targeted shielding can be used and could provide a novel therapeutic target. The resultant increased sACE2 may act as a “dummy” receptor, binding the S protein on circulating virus. [...]hi...
Uloženo v:
| Vydáno v: | The American journal of cardiology Ročník 130; s. 161 - 162 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
01.09.2020
Elsevier Limited |
| Témata: | |
| ISSN: | 0002-9149, 1879-1913, 1879-1913 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | [...]we propose that measurement of ACE2 level may help identify individuals at risk of severe infection where targeted shielding can be used and could provide a novel therapeutic target. The resultant increased sACE2 may act as a “dummy” receptor, binding the S protein on circulating virus. [...]higher numbers of ACE2 receptors expressed before first binding event may lead to higher sACE2 level and reduced circulating SARS-CoV-2 with “active” S protein sites, reduced numbers of affected host cells, and less systemic impact. [...]conditions that upregulate ACE2 may confer protection, whereas reduced ACE2 expression may result in more severe disease. |
|---|---|
| Bibliografie: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Correspondence-1 |
| ISSN: | 0002-9149 1879-1913 1879-1913 |
| DOI: | 10.1016/j.amjcard.2020.06.002 |